Answers are grounded in this paper and cite their sources.
Systematic review evaluates early deep brain stimulation's impact on motor outcomes in Parkinson's disease, indicating potential benefits over medical therapy alone.
BACKGROUND: Parkinson's disease (PD) causes progressive motor and non-motor disability. Although pharmacotherapy is first-line, responses diminish over time. Deep brain stimulation (DBS) effectively treats advanced PD, and recent data suggest benefits when applied earlier. OBJECTIVES: To systematically review studies and meta-analyze randomized controlled trials comparing subthalamic DBS plus best medical therapy (BMT) with BMT alone in early PD. METHODS: We conducted a systematic review and meta-analysis according to PRISMA, with a protocol registered in PROSPERO (CRD420251014105). MEDLINE, Embase, and the Cochrane Library (2002-2025) were searched for studies comparing early DBS with BMT in "early" PD. "Early" was variably defined, commonly disease duration 4-8 years or onset of motor complications without significant disability. We included RCTs, secondary analyses, observational studies, and unpublished trials; meta-analyses were restricted to randomized comparisons of early DBS plus BMT versus BMT alone. RESULTS: Studies included younger patients with ≤8 years' PD duration and early motor complications. Pooled RCT data showed a consistent quality-of-life benefit, while motor and medication outcomes directionally favored early STN-DBS but remained heterogeneous and imprecise. Studies suggest safety is broadly comparable to standard-indication DBS. CONCLUSIONS: Offering DBS before advanced disability-particularly in patients <60 years, <10 years from diagnosis, Hoehn-Yahr stage ≤3, early motor complications, and no dementia-may help delay loss of quality of life versus BMT alone. Given few trials and substantial heterogeneity, further large-scale randomized studies are needed to confirm safety, define optimal timing in early PD, and clarify which subgroups benefit most.
No takes yet. Share an insight, caveat, or question.
Araya et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: